Mao Weiming investigates the production and supply of key epidemic prevention drugs and materials

Mao Weiming investigates the production and supply of key epidemic prevention drugs and materials

Read Time:3 Minute, 51 Second

Mao Weiming stressed when investigating the production and supply of key epidemic prevention drugs and supplies

Production with full power, scientific and accurate deployment to better meet the basic needs of the public

On the morning of the 27th, Mao Weiming, deputy secretary of the provincial party committee and governor, came to some pharmaceutical production enterprises in Liuyang City to investigate the production and supply of key epidemic prevention drugs and materials. He stressed the need to thoroughly implement the spirit of General Secretary Xi Jinping’s important speech on the prevention and control of the epidemic, always adhere to the people first, life first, production at full power, and constantly improve the production of pharmaceutical supplies to ensure the bottom line of drug quality and safety, to better meet the basic needs of the masses.

Deng Qunze, secretary-general of the provincial government, participated.

China’s epidemic prevention and control into a new phase, the epidemic prevention and control face a new situation, new tasks, some of the drug demand has increased sharply. How to meet the needs of the masses with drugs, so that the masses have drugs in their hands, the heart does not panic, become a very urgent task at present. Combined with the actual situation in Hunan, the province issued a catalog of 36 allopathic drugs, including Chinese patent medicines, loxoprofen sodium tablets and acetaminophen. At present, all relevant departments are coordinating key supply enterprises to speed up the production of various epidemic prevention drugs, and dynamically monitor and dispatch the production, procurement response, inventory and distribution of epidemic prevention drugs, shortage drugs and commonly used drugs. At present, the province’s production capacity of key epidemic prevention drugs and testing reagents, etc. has been continuously improved, and the market supply and social demand are being gradually met.

“How about the completion of orders, what difficulties are there in the current production and operation?” Coming to Jiudian Pharmaceutical Co., Ltd, Mao Weiming inspected the pharmaceutical workshop on site and learned that the company’s production of antipyretic and analgesic Loxoprofen sodium tablets and cough and phlegm medicine acetylcysteine granules had achieved full production capacity, with a daily output of 3.2 million tablets and 600,000 bags respectively. The People’s Daily also recommended loxoprofen sodium tablets as an alternative medicine to ibuprofen tablets and other anti-epidemic drugs. Mao Weiming encouraged the enterprise to make every effort to speed up the production and further expand the production capacity, and the relevant departments should strengthen the scientific propaganda of relevant alternative drugs to better serve the demand of scientific medicine for the public.

In the solid preparation workshop of Erkang Pharmaceutical Co., Ltd, the person in charge of the enterprise introduced that in order to meet the surge in demand for anti-epidemic drugs and materials, the company quickly adjusted the production line capacity and actively engaged in the production of key anti-epidemic drugs such as acetaminophen tablets. Mao Weiming expressed his affirmation and urged the enterprise to strengthen epidemic prevention and control, implement closed or semi-closed management to ensure normal production operation; relevant departments should strengthen the elements of protection, coordinate and solve the difficult problems in capital, logistics and labor, etc., to create good conditions for the enterprise to speed up production.

During the investigation and study, Mao Weiming stressed that in the face of the new situation and new tasks of epidemic prevention and control, it is crucial to do a good job in the production and supply of key pharmaceutical materials to fight the epidemic. We should implement the main responsibility of drug production enterprises, strengthen the technical transformation and capacity expansion of the production line, produce at full capacity, strict quality control, and turn the capacity into production in time to better serve and protect the province and the country from epidemic drug market demand. To give full play to the role of the provincial medical supplies work task force, strengthen the deployment of resources, optimize the approval process of key drug supplies related to the epidemic, and fully support enterprises to stabilize production and production, resume production and expand production. To strengthen the analysis and research of the epidemic prevention and control situation, comprehensively grasp the production capacity of enterprises in the province, coordinate the production, reserve and scientific deployment of all kinds of key drugs and related alternative drug supplies, increase the support of grass-roots medical institutions, nursing homes, especially in rural areas, to ensure that the current and New Year’s Day and Spring Festival period key drug supplies at a stable price, so that the public can buy, use.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Beijing CDC experts: the risk of reinfection in Beijing is expected to be low in the near future Previous post Beijing CDC experts: the risk of reinfection in Beijing is expected to be low in the near future
Xiamen orderly implementation of the "inhalation" new crown vaccination service Next post Xiamen orderly implementation of the “inhalation” new crown vaccination service